Search

Displaying results 5831 - 5840 of 7604 in total
  1. Drug

    Nicofetamide

    go.drugbank.com/drugs/DB13531
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  2. Drug

    Dimethylaminopropionylphenothiazine

    go.drugbank.com/drugs/DB13672
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  3. Drug

    ACA 125

    go.drugbank.com/drugs/DB05489
    Investigational

    An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new conc...

  4. Drug

    Cat dander extract

    go.drugbank.com/drugs/DB13904
    Approved

    Cat dander extract is either subcutaneously or intracutaneously administered and contains dry cat dander or dry defatted cat pelt.

  5. Drug

    R-851

    go.drugbank.com/drugs/DB05747
    Experimental

    It is expected to be topical treatment for cervical displasia and cervical high-risk human papillomavirus (HPV), the sexually transmitted virus that causes most cases of cervical cancer.

  6. Drug

    AVN-944

    go.drugbank.com/drugs/DB05500
    Investigational

    It is being investigated for the treatment of patients with advanced hematologic malignancies.

  7. Drug

    (6R)-Folinic acid

    go.drugbank.com/drugs/DB03256
    Experimental

    Mixtures: FERPLEX FOL, FERPLEX FOL
  8. Drug

    Hyperforin

    go.drugbank.com/drugs/DB01892
    InvestigationalNutraceutical

    Hyperforin is a phytochemical generated by the plants of the Hypericum family. One of the most important members of this family, due to its medical properties, is Hypericum perforatum, also known as St John's wort.

  9. Drug

    Zenarestat

    go.drugbank.com/drugs/DB02132
    Experimental

  10. Drug

    Itolizumab

    go.drugbank.com/drugs/DB16207
    Investigational

    Itolizumab is under investigation in clinical trial NCT04605926 (A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19).